Therefore, increasing the expressions of miR-124 and MARCKS by silencing HDAC1 to reduce synovial cell proliferation and synovial inflammation in CIA is a promising new strategy for RA treatment as evidenced from the results in the mouse model (41). The gene discussed is HDAC1; the disease is rheumatoid arthritis.